Reach Us +441234923305


Editor - Angelica M. Merlot | The University of Sydney | 21558
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Angelica M. Merlot

Angelica M. Merlot
Angelica Merlot
Faculty of Medicine
Molecular Pharmacology and Pathology
Pathology Department, Bosch Institute
The University of Sydney
The University of Sydney


Dr. Angelica Merlot is a Postdoctoral Research Associate in the Pathology Department of the University of Sydney. She heads the Cancer Therapeutics Group within the Molecular Pharmacology and Pathology Program. During her PhD, she investigated the pharmacological mechanisms of action and membrane transport of anti-cancer thiosemicarbazones. The most potent agent of this class is entering clinical trials in 2016. Angelica is interested in improving the targeting and pharmacological complications of cancer therapies that cause toxicity and drug resistance. Her current research focuses on the characterization of the endoplasmic reticulum stress pathways in cancer and modulating these signals to induce cancer cell death and inhibit metastasis.

Research Interest

Oncology, Drug Delivery, Albumin, ER Stress, Endocytosis, Metastasis, Cell Biology, Membrane Transport, Cancer Cell Biology, Iron Metabolism, Chemotherapy, Molecular Biology.